Performance of a rapid, on-site human immunodeficiency virus antibody assay in a public health setting.


Rapid, on-site human immunodeficiency virus (HIV) testing has the potential to improve the delivery of prevention services in publicly funded counseling and testing sites. The Single Use Diagnostic System (SUDS) HIV-1 is the only rapid enzyme immunoassay (EIA) approved for diagnostic use in the United States. To evaluate the feasibility of using SUDS in… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.